ADC Therapeutics
Develops proprietary antibody drugs targeting cancer. Learn more
Launch date
Employees
Market cap
€272m
Enterprise valuation
€113m (Public information from Sep 2024)
Share price
$3.1 ADCT
Company register number CH-550.1.094.173-1
Epalinges Canton of Vaud (HQ)
Authorizing premium user...